Chapter 7 Molecular Imaging of Tumor Vasculature

Methods in Enzymology

Volumn 445, Issue , 2008, Pages 141-176

  Cai, Weibo ^a,b   Gambhir, Sanjiv S ^a   Chen, Xiaoyuan ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; COPPER 64; MOLECULAR MARKER; NANOPARTICLE; VASCULOTROPIN 121; VASCULOTROPIN RECEPTOR; VITRONECTIN RECEPTOR;

ANGIOGENESIS; BINDING ASSAY; BLOOD VESSEL; CANCER GROWTH; CELL LABELING; CELL LINE; COMPUTER ASSISTED TOMOGRAPHY; CONJUGATION; HUMAN; IMMUNOFLUORESCENCE; ISOTOPE LABELING; MOLECULAR IMAGING; MOLECULAR PROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STAINING; TUMOR VASCULARIZATION; ULTRASOUND;

EID: 56049090790     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(08)03007-3     Document Type: Review

References (134)

1. M.V. Backer T.I. Gaynutdinov V. Patel A.K. Bandyopadhyaya B.T. Thirumamagal W. Tjarks R.F. Barth K. Claffey J.M. Backer Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature Mol. Cancer Ther. 4 2005 1423 1429
2. M.V. Backer Z. Levashova V. Patel B.T. Jehning K. Claffey F.G. Blankenberg J.M. Backer Molecular imaging of VEGF receptors in angiogenic vasculature with single‐chain VEGF‐based probes Nat. Med. 13 2007 504 509
3. M.V. Backer V. Patel B.T. Jehning J.M. Backer Self‐assembled “dock and lock” system for linking payloads to targeting proteins Bioconjug. Chem. 17 2006 912 919
4. C. Baudelet G.O. Cron B. Gallez Determination of the maturity and functionality of tumor vasculature by MRI: Correlation between BOLD‐MRI and DCE‐MRI using P792 in experimental fibrosarcoma tumors Magn. Reson. Med. 56 2006 1041 1049
5. G. Bergers L.E. Benjamin Tumorigenesis and the angiogenic switch Nat. Rev. Cancer 3 2003 401 410
6. T. Beyer D.W. Townsend T. Brun P.E. Kinahan M. Charron R. Roddy J. Jerin J. Young L. Byars R. Nutt A combined PET/CT scanner for clinical oncology J. Nucl. Med. 41 2000 1369 1379
7. S. Bisdas G.N. Konstantinou P.S. Lee C.H. Thng J. Wagenblast M. Baghi T.S. Koh Dynamic contrast‐enhanced CT of head and neck tumors: Perfusion measurements using a distributed‐parameter tracer kinetic model. Initial results and comparison with deconvolution‐based analysis Phys. Med. Biol. 52 2007 6181 6196
8. F.G. Blankenberg M.V. Backer Z. Levashova V. Patel J.M. Backer In vivo tumor angiogenesis imaging with site‐specific labeled 99mTc‐HYNIC‐VEGF Eur. J. Nucl. Med. Mol. Imaging 33 2006 841 848
9. F.G. Blankenberg S. Mandl Y.A. Cao C. O'Connell‐Rodwell C. Contag C. Mari T.I. Gaynutdinov J.L. Vanderheyden M.V. Backer J.M. Backer Tumor imaging using a standardized radiolabeled adapter protein docked to vascular endothelial growth factor J. Nucl. Med. 45 2004 1373 1380
10. S.H. Bloch P.A. Dayton K.W. Ferrara Targeted imaging using ultrasound contrast agents. Progess and opportunities for clinical and research applications IEEE Eng. Med. Biol. Mag. 23 2004 18 29
11. T. Bogenrieder M. Herlyn Axis of evil: Molecular mechanisms of cancer metastasis Oncogene 22 2003 6524 6536
12. P.C. Brooks S. Stromblad L.C. Sanders T.L. von Schalscha R.T. Aimes W.G. Stetler‐Stevenson J.P. Quigley D.A. Cheresh Localization of matrix metalloproteinase MMP‐2 to the surface of invasive cells by interaction with integrin avb3 Cell 85 1996 683 693
13. W. Cai K. Chen L. He Q. Cao A. Koong X. Chen Quantitative PET of EGFR expression in xenograft‐bearing mice using 64Cu‐labeled cetuximab, a chimeric anti‐EGFR monoclonal antibody Eur. J. Nucl. Med. Mol. Imaging 34 2007 850 858
14. W. Cai K. Chen Z.B. Li S.S. Gambhir X. Chen Dual‐function probe for PET and near‐infrared fluorescence imaging of tumor vasculature J. Nucl. Med. 48 2007 1862 1870
15. W. Cai K. Chen K.A. Mohamedali Q. Cao S.S. Gambhir M.G. Rosenblum X. Chen PET of vascular endothelial growth factor receptor expression J. Nucl. Med. 47 2006 2048 2056
16. W. Cai X. Chen Anti‐angiogenic cancer therapy based on integrin avb3 antagonism Anti‐Cancer Agents Med. Chem. 6 2006 407 428
17. W. Cai X. Chen Multimodality imaging of vascular endothelial growth factor and vascular endothelial growth factor receptor expression Front. Biosci. 12 2007 4267 4279
18. W. Cai X. Chen Nanoplatforms for targeted molecular imaging in living subjects Small 3 2007 1840 1854
19. W. Cai X. Chen Multimodality imaging of tumor angiogenesis J. Nucl. Med. 49 2008 113S 128S
20. W. Cai X. Chen Preparation of peptide conjugated quantum dots for tumour vasculature targeted imaging Nat. Protoc. 3 2008 89 96
21. W. Cai A. Ebrahimnejad K. Chen Q. Cao Z.B. Li D.A. Tice X. Chen Quantitative radioimmunoPET imaging of EphA2 in tumour‐bearing mice Eur. J. Nucl. Med. Mol. Imaging 34 2007 2024 2036
22. W. Cai S.S. Gambhir X. Chen Multimodality tumor imaging targeting integrin avb3 Biotechniques 39 2005 S6 S17
23. W. Cai A.R. Hsu Z.B. Li X. Chen Are quantum dots ready for in vivo imaging in human subjects? Nanoscale Res. Lett. 2 2007 265 281
24. W. Cai T. Olafsen X. Zhang Q. Cao S.S. Gambhir L.E. Williams A.M. Wu X. Chen PET imaging of colorectal cancer in xenograft‐bearing mice by use of an 18F‐labeled T84.66 anti‐carcinoembryonic antigen diabody J. Nucl. Med. 48 2007 304 310
25. W. Cai J. Rao S.S. Gambhir X. Chen How molecular imaging is speeding up anti‐angiogenic drug development Mol. Cancer Ther. 5 2006 2624 2633
26. W. Cai D.W. Shin K. Chen O. Gheysens Q. Cao S.X. Wang S.S. Gambhir X. Chen Peptide‐labeled near‐infrared quantum dots for imaging tumor vasculature in living subjects Nano Lett. 6 2006 669 676
27. W. Cai Y. Wu K. Chen Q. Cao D.A. Tice X. Chen In vitro and in vivo characterization of 64Cu‐labeled AbegrinTM, a humanized monoclonal antibody against integrin avb3 Cancer Res. 66 2006 9673 9681
28. W. Cai X. Zhang Y. Wu X. Chen A thiol‐reactive 18F‐labeling agent, N‐[2‐(4–18F‐fluorobenzamido)ethyl]maleimide (18F‐FBEM), and the synthesis of RGD peptide–based tracer for PET imaging of avb3 integrin expression J. Nucl. Med. 47 2006 1172 1180
29. C. Catana Y. Wu M.S. Judenhofer J. Qi B.J. Pichler S.R. Cherry Simultaneous acquisition of multislice PET and MR images: initial results with a MR‐compatible PET scanner J. Nucl. Med. 47 2006 1968 1976
30. C. Chan J. Sandhu A. Guha D.A. Scollard J. Wang P. Chen K. Bai L. Lee R.M. Reilly A human transferrin–vascular endothelial growth factor (hnTf‐VEGF) fusion protein containing an integrated binding site for 111In for imaging tumor angiogenesis J. Nucl. Med. 46 2005 1745 1752
31. Chatziioannou, A.F. Instrumentation for molecular imaging in preclinical research: Micro‐PET and Micro‐SPECT. Proc. Am. Thorac. Soc. 2, 533–536
32. K. Chen W. Cai Z.B. Li H. Wang X. Chen Quantitative PET imaging of VEGF receptor expression Mol. Imaging Biol. Sep 11. [Epub ahead of print] 2008
33. P.L. Choyke A.J. Dwyer M.V. Knopp Functional tumor imaging with dynamic contrast‐enhanced magnetic resonance imaging J. Magn. Reson. Imaging 17 2003 509 520
34. D.R. Collingridge V.A. Carroll M. Glaser E.O. Aboagye S. Osman O.C. Hutchinson H. Barthel S.K. Luthra F. Brady R. Bicknell P. Price A.L. Harris The development of [124I]iodinated‐VG76e: A novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography Cancer Res. 62 2002 5912 5919
35. B. Cornelissen R. Oltenfreiter V. Kersemans L. Staelens F. Frankenne J.M. Foidart G. Slegers In vitro and in vivo evaluation of [123I]‐VEGF165 as a potential tumor marker Nucl. Med. Biol. 32 2005 431 436
36. S. De O. Razorenova N.P. McCabe T. O'Toole J. Qin T.V. Byzova VEGF‐integrin interplay controls tumor growth and vascularization Proc. Natl. Acad. Sci. USA 102 2005 7589 7594
37. F. Demsar T.P. Roberts H.C. Schwickert D.M. Shames C.F. van Dijke J.S. Mann M. Saeed R.C. Brasch A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution Magn. Reson. Med. 37 1997 236 242
38. A. Dimitrakopoulou‐Strauss L.G. Strauss C. Burger Quantitative PET studies in pretreated melanoma patients: A comparison of 6‐[18F]fluoro‐L‐dopa with 18F‐FDG and 15O‐water using compartment and noncompartment analysis J. Nucl. Med. 42 2001 248 256
39. D.B. Ellegala H. Leong‐Poi J.E. Carpenter A.L. Klibanov S. Kaul M.E. Shaffrey J. Sklenar J.R. Lindner Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to avb3 Circulation 108 2003 336 341
40. E. Even‐Sapir H. Lerman G. Lievshitz A. Khafif D.M. Fliss A. Schwartz E. Gur Y. Skornick S. Schneebaum Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system J. Nucl. Med. 44 2003 1413 1420
41. N. Ferrara VEGF and the quest for tumour angiogenesis factors Nat. Rev. Cancer 2 2002 795 803
42. N. Ferrara Vascular endothelial growth factor: Basic science and clinical progress Endocr. Rev. 25 2004 581 611
43. N. Ferrara The role of VEGF in the regulation of physiological and pathological angiogenesis EXS 94 2005 209 231
44. C. Fink F. Kiessling M. Bock M.P. Lichy B. Misselwitz P. Peschke N.E. Fusenig R. Grobholz S. Delorme High‐resolution three‐dimensional MR angiography of rodent tumors: Morphologic characterization of intratumoral vasculature J. Magn. Reson. Imaging 18 2003 59 65
45. A.C. Fleischer W.E. Wojcicki E.F. Donnelly D.R. Pickens G. Thirsk G.B. Thurman C.G. Hellerqvist Quantified color Doppler sonography of tumor vascularity in an animal model J. Ultrasound Med. 18 1999 547 551
46. J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease Nat. Med. 1 1995 27 31
47. J. Folkman Angiogenesis: An organizing principle for drug discovery? Nat. Rev. Drug Discov. 6 2007 273 286
48. E. Fonsatti M. Altomonte M.R. Nicotra P.G. Natali M. Maio Endoglin (CD105): A powerful therapeutic target on tumor‐associated angiogenetic blood vessels Oncogene 22 2003 6557 6563
49. F. Forsberg R.J. Ro M. Potoczek J.B. Liu C.R. Merritt K.M. James A.P. Dicker L.N. Nazarian Assessment of angiogenesis: implications for ultrasound imaging Ultrasonics 42 2004 325 330
50. F.S. Foster P.N. Burns D.H. Simpson S.R. Wilson D.A. Christopher D.E. Goertz Ultrasound for the visualization and quantification of tumor microcirculation Cancer Metastasis Rev. 19 2000 131 138
51. J.V. Frangioni In vivo near‐infrared fluorescence imaging Curr. Opin. Chem. Biol. 7 2003 626 634
52. P. Friedl K. Wolf Tumour‐cell invasion and migration: Diversity and escape mechanisms Nat. Rev. Cancer 3 2003 362 374
53. M.A. Haider M. Milosevic A. Fyles I. Sitartchouk I. Yeung E. Henderson G. Lockwood T.Y. Lee T.P. Roberts Assessment of the tumor microenvironment in cervix cancer using dynamic contrast enhanced CT, interstitial fluid pressure and oxygen measurements Int. J. Radiat. Oncol. Biol. Phys. 62 2005 1100 1107
54. D. Hanahan J. Folkman Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 1996 353 364
55. H.A. Haroon T.F. Patankar X.P. Zhu K.L. Li N.A. Thacker M.J. Scott A. Jackson Comparison of cerebral blood volume maps generated from T2* and T1 weighted MRI data in intra‐axial cerebral tumours Br. J. Radiol. 80 2007 161 168
56. H. Hashizume P. Baluk S. Morikawa J.W. McLean G. Thurston S. Roberge R.K. Jain D.M. McDonald Openings between defective endothelial cells explain tumor vessel leakiness Am. J. Pathol. 156 2000 1363 1380
57. D.J. Hicklin L.M. Ellis Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis J. Clin. Oncol. 23 2005 1011 1027
58. J.D. Hood D.A. Cheresh Role of integrins in cell invasion and migration Nat. Rev. Cancer 2 2002 91 100
59. A.R. Hsu W. Cai A. Veeravagu K.A. Mohamedali K. Chen S. Kim H. Vogel L.C. Hou V. Tse M.G. Rosenblum X. Chen Multimodality molecular imaging of glioblastoma growth inhibition with vasculature‐targeting fusion toxin VEGF121/rGel J. Nucl. Med. 48 2007 445 454
60. Y.Y. Hsu C.N. Chang S.M. Jung K.E. Lim J.C. Huang S.Y. Fang H.L. Liu Blood oxygenation level–dependent MRI of cerebral gliomas during breath holding J. Magn. Reson. Imaging 19 2004 160 167
61. G. Hu M. Lijowski H. Zhang K.C. Partlow S.D. Caruthers G. Kiefer G. Gulyas P. Athey M.J. Scott S.A. Wickline G.M. Lanza Imaging of Vx‐2 rabbit tumors with avb3‐integrin–targeted 111In nanoparticles Int. J. Cancer 120 2007 1951 1957
62. M.S. Hughes J.N. Marsh H. Zhang A.K. Woodson J.S. Allen E.K. Lacy C. Carradine G.M. Lanza S.A. Wickline Characterization of digital waveforms using thermodynamic analogs: Detection of contrast‐targeted tissue in vivo IEEE Trans. Ultrason. Ferroelectr. Freq. Control 53 2006 1609 1616
63. R.O. Hynes Integrins: bidirectional, allosteric signaling machines Cell 110 2002 673 687
64. G.C. Jayson J. Zweit A. Jackson C. Mulatero P. Julyan M. Ranson L. Broughton J. Wagstaff L. Hakannson G. Groenewegen J. Bailey N. Smith Molecular imaging and biological evaluation of HuMV833 anti‐VEGF antibody: Implications for trial design of antiangiogenic antibodies J. Natl. Cancer Inst. 94 2002 1484 1493
65. Y. Jiang J. Zhao D.L. White H.K. Genant Micro CT and Micro MR imaging of 3D architecture of animal skeleton J. Musculoskelet. Neuronal Interact. 1 2000 45 51
66. R. Kerbel J. Folkman Clinical translation of angiogenesis inhibitors Nat. Rev. Cancer 2 2002 727 739
67. B.A. Keyt H.V. Nguyen L.T. Berleau C.M. Duarte J. Park H. Chen N. Ferrara Identification of vascular endothelial growth factor determinants for binding KDR and FLT‐1 receptors. Generation of receptor‐selective VEGF variants by site‐directed mutagenesis J. Biol. Chem. 271 1996 5638 5646
68. H. Kobayashi N. Sato S. Kawamoto T. Saga A. Hiraga T. Ishimori J. Konishi K. Togashi M.W. Brechbiel 3D MR angiography of intratumoral vasculature using a novel macromolecular MR contrast agent Magn. Reson. Med. 46 2001 579 585
69. M.A. Konerding A.J. Miodonski A. Lametschwandtner Microvascular corrosion casting in the study of tumor vascularity: A review Scanning Microsc. 9 1995 1233 1243 discussion 1243–1234
70. G. Korpanty J.G. Carbon P.A. Grayburn J.B. Fleming R.A. Brekken Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature Clin. Cancer Res. 13 2007 323 330
71. G. Korpanty P.A. Grayburn R.V. Shohet R.A. Brekken Targeting vascular endothelium with avidin microbubbles Ultrasound Med. Biol. 31 2005 1279 1283
72. K.J. Lankester J.N. Taylor J.J. Stirling J. Boxall J.A. d'Arcy D.J. Collins S. Walker‐Samuel M.O. Leach G.J. Rustin A.R. Padhani Dynamic MRI for imaging tumor microvasculature: Comparison of susceptibility and relaxivity techniques in pelvic tumors J. Magn. Reson. Imaging 25 2007 796 805
73. H.Y. Lee Z.B. Li K. Chen A.R. Hsu C. Xu J. Xie S. Sun X. Chen PET/MRI dual‐modality tumor imaging using arginine‐glycine‐aspartic (RGD)–conjugated radiolabeled iron oxide nanoparticles J. Nucl. Med. 49 2008 1371 1379
74. J.R. Less T.C. Skalak E.M. Sevick R.K. Jain Microvascular architecture in a mammary carcinoma: Branching patterns and vessel dimensions Cancer Res. 51 1991 265 273
75. R.M. Levenson Spectral imaging and pathology: Seeing more Lab. Med. 35 2004 244 251
76. S. Li M. Peck‐Radosavljevic O. Kienast J. Preitfellner G. Hamilton A. Kurtaran C. Pirich P. Angelberger R. Dudczak Imaging gastrointestinal tumours using vascular endothelial growth factor‐165 (VEGF165) receptor scintigraphy Ann. Oncol. 14 2003 1274 1277
77. S. Li M. Peck‐Radosavljevic O. Kienast J. Preitfellner E. Havlik W. Schima T. Traub‐Weidinger S. Graf M. Beheshti M. Schmid P. Angelberger R. Dudczak Iodine‐123–vascular endothelial growth factor‐165 (123I‐VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma Q. J. Nucl. Med. Mol. Imaging 48 2004 198 206
78. S. Li M. Peck‐Radosavljevic E. Koller F. Koller K. Kaserer A. Kreil S. Kapiotis A. Hamwi H.A. Weich P. Valent P. Angelberger R. Dudczak I. Virgolini Characterization of 123I‐vascular endothelial growth factor‐binding sites expressed on human tumour cells: Possible implication for tumour scintigraphy Int. J. Cancer 91 2001 789 796
79. Z.B. Li W. Cai X. Chen Semiconductor quantum dots for in vivo imaging J. Nanosci. Nanotechnol. 7 2007 2567 2581
80. K. Licha B. Riefke V. Ntziachristos A. Becker B. Chance W. Semmler Hydrophilic cyanine dyes as contrast agents for near‐infrared tumor imaging: Synthesis, photophysical properties and spectroscopic in vivo characterization Photochem. Photobiol. 72 2000 392 398
81. S. Liu Radiolabeled multimeric cyclic RGD peptides as integrin avb3 targeted radiotracers for tumor imaging Mol. Pharm. 3 2006 472 487
82. T.T. Liu G.G. Brown Measurement of cerebral perfusion with arterial spin labeling: Part 1. Methods J. Int. Neuropsychol. Soc. 13 2007 517 525
83. Z. Liu W. Cai L. He N. Nakayama K. Chen X. Sun X. Chen H. Dai In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice Nat. Nanotechnol. 2 2007 47 52
84. D.A. Mankoff A definition of molecular imaging J. Nucl. Med. 48 2007 18N21N
85. J.R. Mansfield K.W. Gossage C.C. Hoyt R.M. Levenson Autofluorescence removal, multiplexing, and automated analysis methods for in vivo fluorescence imaging J. Biomed. Opt. 10 2005 41207
86. T.F. Massoud S.S. Gambhir Molecular imaging in living subjects: Seeing fundamental biological processes in a new light Genes Dev. 17 2003 545 580
87. M.R. McDevitt D. Chattopadhyay B.J. Kappel J.S. Jaggi S.R. Schiffman C. Antczak J.T. Njardarson R. Brentjens D.A. Scheinberg Tumor targeting with antibody‐functionalized, radiolabeled carbon nanotubes J. Nucl. Med. 48 2007 1180 1189
88. D.M. McDonald P.L. Choyke Imaging of angiogenesis: From microscope to clinic Nat. Med. 9 2003 713 725
89. C.F. Meares M.J. McCall D.T. Reardan D.A. Goodwin C.I. Diamanti M. McTigue Conjugation of antibodies with bifunctional chelating agents: Isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions Anal. Biochem. 142 1984 68 78
90. M. Miettinen A.E. Lindenmayer A. Chaubal Endothelial cell markers CD31, CD34, and BNH9 antibody to H‐ and Y‐antigens—evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor Mod. Pathol. 7 1994 82 90
91. X. Montet J.L. Figueiredo H. Alencar V. Ntziachristos U. Mahmood R. Weissleder Tomographic fluorescence imaging of tumor vascular volume in mice Radiology 242 2007 751 758
92. X. Montet V. Ntziachristos J. Grimm R. Weissleder Tomographic fluorescence mapping of tumor targets Cancer Res. 65 2005 6330 6336
93. T. Motoike S. Loughna E. Perens B.L. Roman W. Liao T.C. Chau C.D. Richardson T. Kawate J. Kuno B.M. Weinstein D.Y. Stainier T.N. Sato Universal GFP reporter for the study of vascular development Genesis 28 2000 75 81
94. W.J. Mulder G.J. Strijkers J.W. Habets E.J. Bleeker D.W. van der Schaft G. Storm G.A. Koning A.W. Griffioen K. Nicolay MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle FASEB J. 19 2005 2008 2010
95. N. Mullani R. Herbst J. Abbruzzese B. Barron L. Lamki C. Charnsangavej E. Kim H. Tran A. Jiwani K. Gould 9:30–9:45. First pass FDG measured blood flow in tumors: A comparison with O‐15 labeled water measured blood flow Clin. Positron Imaging 3 2000 153
96. W.B. Nagengast E.G. de Vries G.A. Hospers N.H. Mulder J.R. de Jong H. Hollema A.H. Brouwers G.A. van Dongen L.R. Perk M.N. Lub‐de Hooge In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft J. Nucl. Med. 48 2007 1313 1319
97. G. Niu Z. Xiong Z. Cheng W. Cai S.S. Gambhir L. Xing X. Chen In vivo bioluminescence tumor imaging of RGD peptide‐modified adenoviral vector encoding firefly luciferase reporter gene Mol. Imaging Biol. 9 2007 126 134
98. J.P. O'Connor A. Jackson G.J. Parker G.C. Jayson DCE‐MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents Br. J. Cancer 96 2007 189 195
99. R.C. Orth J. Bankson R. Price E.F. Jackson Comparison of single‐ and dual‐tracer pharmacokinetic modeling of dynamic contrast‐enhanced MRI data using low, medium, and high molecular weight contrast agents Magn. Reson. Med. 58 2007 705 716
100. D.M. Parkin Global cancer statistics in the year (2000) Lancet Oncol. 2 2001 533 543
101. D.M. Parkin P. Pisani J. Ferlay Estimates of the worldwide incidence of 25 major cancers in 1990 Int. J. Cancer 80 1999 827 841
102. K. Peremans B. Cornelissen B. Van Den Bossche K. Audenaert C. Van de Wiele A review of small animal imaging planar and pinhole spect Gamma camera imaging Vet. Radiol. Ultrasound 46 2005 162 170
103. P. Pisani D.M. Parkin F. Bray J. Ferlay Estimates of the worldwide mortality from 25 cancers in (1990) Int. J. Cancer 83 1999 18 29
104. A. Preda V. Novikov M. Moglich K. Turetschek D.M. Shames R.C. Brasch F.M. Cavagna T.P. Roberts MRI monitoring of Avastin antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer J. Magn. Reson. Imaging 20 2004 865 873
105. C. Roberts B. Issa A. Stone A. Jackson J.C. Waterton G.J. Parker Comparative study into the robustness of compartmental modeling and model‐free analysis in DCE‐MRI studies J. Magn. Reson. Imaging 23 2006 554 563
106. E.M. Rohren T.G. Turkington R.E. Coleman Clinical applications of PET in oncology Radiology 231 2004 305 332
107. T.M. Schlaeger S. Bartunkova J.A. Lawitts G. Teichmann W. Risau U. Deutsch T.N. Sato Uniform vascular‐endothelial‐cell–specific gene expression in both embryonic and adult transgenic mice Proc. Natl. Acad. Sci. USA 94 1997 3058 3063
108. R.O. Schlingemann F.J. Rietveld F. Kwaspen P.C. van de Kerkhof R.M. de Waal D.J. Ruiter Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue Am. J. Pathol. 138 1991 1335 1347
109. A.H. Schmieder P.M. Winter S.D. Caruthers T.D. Harris T.A. Williams J.S. Allen E.K. Lacy H. Zhang M.J. Scott G. Hu J.D. Robertson S.A. Wickline Molecular MR imaging of melanoma angiogenesis with avb3‐targeted paramagnetic nanoparticles Magn. Reson. Med. 53 2005 621 627
110. R.V. Shohet S. Chen Y.T. Zhou Z. Wang R.S. Meidell R.H. Unger P.A. Grayburn Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium Circulation 101 2000 2554 2556
111. M. Simon W. Rockl C. Hornig E.F. Grone H. Theis H.A. Weich E. Fuchs A. Yayon H.J. Grone Receptors of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in fetal and adult human kidney: Localization and [125I]VEGF‐binding sites J. Am. Soc. Nephrol. 9 1998 1032 1044
112. R. Singh D. Pantarotto L. Lacerda G. Pastorin C. Klumpp M. Prato A. Bianco K. Kostarelos Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers Proc. Natl. Acad. Sci. USA 103 2006 3357 3362
113. D.A. Sipkins D.A. Cheresh M.R. Kazemi L.M. Nevin M.D. Bednarski K.C. Li Detection of tumor angiogenesis in vivo by avb3‐targeted magnetic resonance imaging Nat. Med. 4 1998 623 626
114. S.S. Spencer W.H. Theodore S.F. Berkovic Clinical applications: MRI, SPECT, and PET Magn. Reson. Imaging 13 1995 1119 1124
115. E. Stride N. Saffari Microbubble ultrasound contrast agents: A review Proc. Inst. Mech. Eng. [H] 217 2003 429 447
116. M.M. Ter‐Pogossian P. Herscovitch Radioactive oxygen‐15 in the study of cerebral blood flow, blood volume, and oxygen metabolism Semin. Nucl. Med. 15 1985 377 394
117. D.W. Townsend T. Beyer A combined PET/CT scanner: The path to true image fusion Br. J. Radiol. 75 2002 S24 S30
118. G.M. Tozer S.M. Ameer‐Beg J. Baker P.R. Barber S.A. Hill R.J. Hodgkiss R. Locke V.E. Prise I. Wilson B. Vojnovic Intravital imaging of tumour vascular networks using multi‐photon fluorescence microscopy Adv. Drug Deliv. Rev. 57 2005 135 152
119. M.J. Trotter P.L. Olive D.J. Chaplin Effect of vascular marker Hoechst 33342 on tumour perfusion and cardiovascular function in the mouse Br. J. Cancer 62 1990 903 908
120. T.L. Underiner B. Ruggeri D.E. Gingrich Development of vascular endothelial growth factor receptor (VEGFR) kinase inhibitors as anti‐angiogenic agents in cancer therapy Curr. Med. Chem. 11 2004 731 745
121. H. Wang W. Cai K. Chen Z.B. Li A. Kashefi L. He X. Chen A new PET tracer specific for vascular endothelial growth factor receptor 2 Eur. J. Nucl. Med. Mol. Imaging 34 2007 2001 2010
122. R. Weissleder U. Mahmood Molecular imaging Radiology 219 2001 316 333
123. D.S. Williams Quantitative perfusion imaging using arterial spin labeling Methods Mol. Med. 124 2006 151 173
124. J.K. Willmann R. Paulmurugan K. Chen O. Gheysens M. Rodriguez‐Porcel A.M. Lutz I.Y. Chen X. Chen S.S. Gambhir US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice Radiology 246 2008 508 518
125. P.M. Winter S.D. Caruthers A. Kassner T.D. Harris L.K. Chinen J.S. Allen E.K. Lacy H. Zhang J.D. Robertson S.A. Wickline G.M. Lanza Molecular imaging of angiogenesis in nascent Vx‐2 rabbit tumors using a novel avb3‐targeted nanoparticle and 1.5 tesla magnetic resonance imaging Cancer Res. 63 2003 5838 5843
126. R.L. Wolf J.A. Detre Clinical neuroimaging using arterial spin‐labeled perfusion magnetic resonance imaging Neurotherapeutics 4 2007 346 359
127. Y. Wu W. Cai X. Chen Near‐infrared fluorescence imaging of tumor integrin avb3 expression with Cy7‐labeled RGD multimers Mol. Imaging Biol. 8 2006 226 236
128. Y. Wu X. Zhang Z. Xiong Z. Cheng D.R. Fisher S. Liu X. Chen MicroPET imaging of glioma av‐integrin expression using 64Cu‐labeled tetrameric RGD peptide J. Nucl. Med. 46 2005 1707 1718
129. J.P. Xiong T. Stehle R. Zhang A. Joachimiak M. Frech S.L. Goodman M.A. Arnaout B. Diefenbach R. Dunker D.L. Scott Crystal structure of the extracellular segment of integrin alpha‐v‐beta3 in complex with an Arg‐Gly‐Asp ligand Science 296 2002 151 155
130. Z. Xiong Z. Cheng X. Zhang M. Patel J.C. Wu S.S. Gambhir X. Chen Imaging chemically modified adenovirus for targeting tumors expressing integrin avb3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene J. Nucl. Med. 47 2006 130 139
131. M. Yoshimoto S. Kinuya A. Kawashima R. Nishii K. Yokoyama K. Kawai Radioiodinated VEGF to image tumor angiogenesis in a LS180 tumor xenograft model Nucl. Med. Biol. 33 2006 963 969
132. C.L. Zavaleta S. Keren Z. Cheng M. Schipper X. Chen H. Dai Z. Liu S.S. Gambhir Use of non‐invasive raman spectroscopy imaging in living mice for evaluation of tumor targeting with carbon nanotubes Presented at Joint Molecular Imaging Conference, Providence, RI, Abstract 85 2007
133. C. Zhang M. Jugold E.C. Woenne T. Lammers B. Morgenstern M.M. Mueller H. Zentgraf M. Bock M. Eisenhut W. Semmler F. Kiessling Specific targeting of tumor angiogenesis by RGD‐conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5‐T magnetic resonance scanner Cancer Res. 67 2007 1555 1562
134. X. Zhang Z. Xiong X. Wu W. Cai J.R. Tseng S.S. Gambhir X. Chen Quantitative PET imaging of tumor integrin avb3 expression with 18F‐FRGD2 J. Nucl. Med. 47 2006 113 121